Medical News

---

• CMR imaging superior to SPECT for diagnosing coronary heart disease
• Aliskiren trial halted due to adverse effects
• Adverse event risk lasts at least 5 years with sirolimus-eluting stents
• Risk for childhood ADHD raised by gestational diabetes and low maternal SES
• Diabetes patients at increased risk for depression
• Antisense therapy holds promise for treatment-resistant dyslipidemia
• Oat beta-glucan cereal could offer broad LDL cholesterol benefit
• Diabetes patients at increased risk for depression
• Predictors of recanalization failure with iv thrombolysis highlighted
• Adverse event risk lasts at least 5 years with sirolimus-eluting stents

CMR imaging superior to SPECT for diagnosing coronary heart disease Posted: 05 Jan 2012 04:00 PM PST Cardiac magnetic resonance imaging is superior to single-photon emission computed tomography for diagnosing coronary heart disease, a study in The Lancet suggests.

Aliskiren trial halted due to adverse effects Posted: 05 Jan 2012 04:00 PM PST The ALTITUDE trial has been halted due to an increase in adverse events and no apparent benefits among patients treated with the direct renin inhibitor aliskiren.

Adverse event risk lasts at least 5 years with sirolimus-eluting stents Posted: 05 Jan 2012 04:00 PM PST Late adverse events such as very late stent thrombosis and late target lesion revascularization pose a threat to patients for at least 5 years after implantation of a first generation drug-eluting stent, Japanese study data show.

Risk for childhood ADHD raised by gestational diabetes and low maternal SES Posted: 05 Jan 2012 04:00 PM PST Women who experience gestational diabetes and are of low socioeconomic status have an increased risk for having a child with attention-deficit/hyperactivity disorder, suggest study findings.

Diabetes patients at increased risk for depression Posted: 05 Jan 2012 04:00 PM PST Depression is common in patients with Type 2 diabetes and, once present, often becomes a chronic or recurrent condition, a study shows.

Antisense therapy holds promise for treatment-resistant dyslipidemia Posted: 05 Jan 2012 04:00 PM PST Review findings suggest that patients with treatment-resistant dyslipidemia may benefit from antisense therapy with mipomersen, an antisense molecule capable of producing clinically meaningful reductions in low-density lipoprotein cholesterol.

Oat beta-glucan cereal could offer broad LDL cholesterol benefit Posted: 05 Jan 2012 04:00 PM PST Researchers report that both Caucasians and non-Caucasians can benefit from the low-density lipoprotein-cholesterol-lowering effect of oat beta-glucan.

Diabetes patients at increased risk for depression Posted: 05 Jan 2012 04:00 PM PST Depression is common in patients with Type 2 diabetes and, once present, often becomes a chronic or recurrent condition, a study shows.

Predictors of recanalization failure with iv thrombolysis highlighted Posted: 05 Jan 2012 04:00 PM PST Clinical factors that predict whether patients will recanalize when given intravenous tissue plasminogen activator vary with the site of occlusion, a study shows.

Adverse event risk lasts at least 5 years with sirolimus-eluting stents Posted: 05 Jan 2012 04:00 PM PST Late adverse events such as very late stent thrombosis and late target lesion revascularization pose a threat to patients for at least 5 years after implantation of a first generation drug-eluting stent, Japanese study data show.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610